Moderna on Wednesday said its combination vaccine targeting Covid and the flu will move to a final stage trial after showing positive results in an earlier study.
The biotech company is hoping its shot, mRNA-1083, can win approval from regulators in 2025.
A large study from Singapore suggests that COVID-19 infection increased the risk of new-onset cardiovascular and cerebrovascular complications during the Delta variant era and that vaccination lowered the risk.
US COVID-19 hospitalizations and deaths continued their slow rise over the past week, but two early indicators showed declines, the Centers for Disease Control and Prevention (CDC) said in its latest data update.
Two new studies describe the benefits of the antiviral drugs nirmatrelvir-ritonavir (Paxlovid) and molnupiravir in reducing SARS-CoV-2 Omicron hospitalizations and death, with one finding that the former is more effective than the latter at lowering death rates.
Recent Comments